Table 2 |
|||
|
Treatment by setting for hyponatremia patients |
|||
| Inpatient |
ER |
Office/Clinic |
|
|
|
|||
| Low Scenario (3.16 million prevalence; 1.17 million treated patients) |
|||
| Overall |
63% (738,778) |
24% (280,988) |
13% (148,387) |
| Acute and Symptomatic |
75% (23,679) |
25% (7,893) |
0% (0) |
| Acute and Asymptomatic |
75% (94,715) |
25% (31,572) |
0% (0) |
| Chronic and Symptomatic |
45% (241,524) |
45% (241,524) |
10% (53,672) |
| Chronic and Asymptomatic |
80% (378,861) |
0% (0) |
20% (94,715) |
|
|
|||
| High Scenario (6.07 million prevalence; 1.35 million treated patients) |
|||
|
|
|||
| Overall |
55% (738,778) |
25% (333,070) |
20% (274,036) |
| Acute and Symptomatic |
65% (35,530) |
35% (19,131) |
0% (0) |
| Acute and Asymptomatic |
65% (106,590) |
35% (57,394) |
0% (0) |
| Chronic and Symptomatic |
40% (256,544) |
40% (256,544) |
20% (128,272) |
| Chronic and Asymptomatic |
70% (340,115) |
0% (0) |
30% (145,764) |
Boscoe et al. Cost Effectiveness and Resource Allocation 2006 4:10 doi:10.1186/1478-7547-4-10 |
|||
